A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease

NCT07128628 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

423

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: Lifitegrast/Perfluorohexyloctane Fixed Dose Combination
DRUG: Lifitegrast
DRUG: Perfluorohexyloctane
DRUG: Vehicle
DRUG: Vehicle
DRUG: Vehicle

Sponsor

Bausch & Lomb Incorporated